dc.contributor.author | Guler, Emine Nilufer | |
dc.contributor.author | Demir, Atakan | |
dc.contributor.author | Mandel, Nil Molinas | |
dc.contributor.author | PAYDAŞ, SEMRA | |
dc.contributor.author | Demir, Gokhan | |
dc.contributor.author | ER, Ozlem | |
dc.contributor.author | Turhal, Nazim Serdal | |
dc.contributor.author | Bavbek, Sevil | |
dc.contributor.author | Eralp, Yesim | |
dc.contributor.author | Saip, Pinar Mualla | |
dc.contributor.author | Aydiner, Adnan | |
dc.contributor.author | OYAN ULUÇ, Başak | |
dc.contributor.author | Kilickap, Sadettin | |
dc.contributor.author | Uskent, Necdet | |
dc.contributor.author | Karadurmus, Nuri | |
dc.contributor.author | Kaplan, Mehmet Ali | |
dc.contributor.author | Yanmaz, Mustafa Teoman | |
dc.contributor.author | Demir, Hacer | |
dc.contributor.author | Alan, Ozkan | |
dc.contributor.author | KORKMAZ, Taner | |
dc.contributor.author | Olgun, Polat | |
dc.contributor.author | Uysal, Ozlem Sonmez | |
dc.contributor.author | Altundag, Kadri | |
dc.contributor.author | Gunduz, Seyda | |
dc.contributor.author | Gunaldi, Meral | |
dc.contributor.author | Sari, Murat | |
dc.contributor.author | Beypinar, Ismail | |
dc.contributor.author | BAŞARAN, Gül | |
dc.date.accessioned | 2021-03-03T19:42:05Z | |
dc.date.available | 2021-03-03T19:42:05Z | |
dc.date.issued | 2020 | |
dc.identifier.citation | Demir A., Mandel N. M. , PAYDAŞ S., Demir G., ER O., Turhal N. S. , Bavbek S., Eralp Y., Saip P. M. , Guler E. N. , et al., "Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial", BALKAN MEDICAL JOURNAL, cilt.37, sa.2, ss.104-107, 2020 | |
dc.identifier.issn | 2146-3123 | |
dc.identifier.other | av_55f801b5-6322-46ca-a57b-de3d667973b3 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/60714 | |
dc.identifier.uri | https://doi.org/10.4274/balkanmedj.galenos.2020.2019.11.143 | |
dc.description.abstract | Background: The synthesis of CDK4/6 inhibitors with endocrine treatment in two series of treatment has been widely accepted as the standard for patients with estrogen receptor-positive metastatic breast cancer. In spite of this, the activity of CDK4/6 inhibitors in patients with metastatic breast cancer who have progressed despite receiving multiple lines of treatment is not well understood. | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Klinik Tıp | |
dc.subject | Temel Tıp Bilimleri | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | TIP, GENEL & İÇECEK | |
dc.subject | Tıp | |
dc.title | Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial | |
dc.type | Makale | |
dc.relation.journal | BALKAN MEDICAL JOURNAL | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 37 | |
dc.identifier.issue | 2 | |
dc.identifier.startpage | 104 | |
dc.identifier.endpage | 107 | |
dc.contributor.firstauthorID | 2279135 | |